Superworth

Kura Oncology EPS KURA

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$3.37
Latest quarter, Q2 FY26
−$0.77
Fiscal year 2025
−$3.18

Kura Oncology's earnings per share was −$3.37 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.77.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$3.18n/a
FY2024−$2.03n/a
FY2023−$2.08n/a
FY2022−$2.03n/a
FY2021−$1.96n/a
FY2020−$1.69n/a
FY2019−$1.50n/a
FY2018−$1.73n/a
FY2017−$1.54n/a
FY2016−$1.47n/a
FY2015−$2.94n/a
FY2014$0.00n/a
FY2013$0.00n/a
FY2012$0.00n/a
FY2011$0.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.77n/a−$3.37
Q1 FY26−$0.83n/a−$3.35
Q4 FY25−$0.92n/a−$3.18
Q3 FY25−$0.85n/a−$2.48
Q2 FY25−$0.75n/a−$2.26
Q1 FY25−$0.66n/a−$2.10
Q4 FY24−$0.22n/a−$2.03
Q3 FY24−$0.63n/a−$2.36
Q2 FY24−$0.59n/a−$2.23
Q1 FY24−$0.59n/a−$2.17
Q4 FY23−$0.55n/a−$2.08
Q3 FY23−$0.50n/a−$2.02

Against its peers

Companies in Drug Manufacturers - General nearest Kura Oncology's size, closest first, today.

CompanyEPS, 12 monthsGrowth
KURAKura Oncology−$3.37
ABUSArbutus Biopharma$0.78
COLLCollegium Pharmaceutical$1.24+19% a year
AMPHAmphastar Pharmaceuticals$1.70−36% a year
CRMDCorMedix$2.13+184% a year
OMEROmeros$1.52
ZVRAZevra Therapeutics$0.93
IRWDIronwood Pharmaceuticals$0.77
PBYIPuma Biotechnology$0.52−47% a year
PCRXPacira BioSciences$0.35
ANABAnaptysbio$4.57
Peer median$1.08

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Kura Oncology

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.